NCT00361153View on ClinicalTrials.gov

Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

March 31, 2007

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Colesevelam hydrochloride

Welchol tablet 625mg

DRUG

placebo

placebo

Trial Locations (1)

78229

Diabetes and Glandular Research Associates, San Antonio

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY